This Study Tests a New Sound Blade Ultrasound for Thyroid Scans. It Compares Its Images With Regular Hospital Ultrasounds to See Which is Clearer. The Images Will Help Build Future AI Tools to Improve Care.
THYMAL 01
A Novel Ultrasound Probe for Thyroid Imaging and Machine Learning: A Pilot Study
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
This study is testing a new type of ultrasound made just for looking at the thyroid, a small gland in the neck. During one clinic visit, people will have two safe and painless scans: the regular ultrasound they would normally get, and a second scan using the research device. Both scans use a probe on the skin with gel-there are no needles, no radiation, and no changes to their medical care. The goal is to see if the new ultrasound can create clearer pictures and help computer programs find and measure thyroid nodules more accurately. In the future, this may help doctors guide treatments and make them safer and more effective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 27, 2026
CompletedFirst Posted
Study publicly available on registry
March 23, 2026
CompletedStudy Start
First participant enrolled
May 31, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
Study Completion
Last participant's last visit for all outcomes
September 1, 2027
March 23, 2026
February 1, 2026
4 months
February 27, 2026
March 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Part A: Prospective Thyroid Imaging Study Objective: Visualization and Image Quality Assessment of Key Neck Structures Using Ultrasound Visibility Scale and Radiologist Comparison Form
1 Visibility Scale (Primary Component) Independent, blinded radiologists will rate the visibility of each structure using a 3-point scale: 0 = Not Visible (structure cannot be identified) 1. = Partially Visible (structure identifiable but with limited definition) 2. = Fully Visible (structure clearly identified with complete anatomic definition) Scores from each reviewer will be averaged for analysis. 2. Radiologist Comparative Image Quality Form (Secondary of Primary Outcome) Radiologists will complete a structured comparison form evaluating: Size (agreement between devices; measured in mm) Margins (sharp, indistinct, irregular) Edge Definition (well-defined vs. poorly defined) Overall Visibility (device-to-device comparison: better, worse, equivalent) These assessments will be recorded for each thyroid nodule and relevant neck structure. The primary endpoint is the difference in mean visibility scores and qualitative image quality ratings between the investigational and SOC ultrasound
This will take place at month 3 to end of month 7 of study.
Part B: Machine Learning Model Development Objective Develop and internally evaluate a machine-learning model that identifies and segments thyroid nodules and predefined neck structures (carotid, jugular, vagus nerve, trachea, thyroid nodule) on image
Outcome Measure 1: Segmentation Accuracy Performance of the machine-learning model in segmenting thyroid nodules and neck structures (carotid artery, internal jugular vein, vagus nerve, trachea). Accuracy will be evaluated using overlap-based metrics, including the Dice Similarity Coefficient and Intersection-over-Union (IoU). These unitless measures quantify agreement between the model-generated segmentation and expert-annotated reference masks. Outcome Measure 2: Visibility and Detection Performance Performance of the model in identifying the presence or absence of thyroid nodules and key neck structures on ultrasound images. Detection quality will be assessed using standard classification metrics, including sensitivity, specificity, positive predictive value, negative predictive value, and area under the ROC curve (AUC). These metrics quantify diagnostic accuracy. Outcome Measure 3: 3-D Reconstruction and Focus-Tracking Feasibility Feasibility of generating consistent 3-D thyroid
At month 4 until then end of the study, month 12.
Study Arms (1)
Participants who are scheduled for a SOC surveillance Thyroid Nodule Ultrasound
EXPERIMENTALPatients who are scheduled for a SOC surveillance Thyroid Nodule Ultrasound after signing consent will undergo a second ultrasound using the Sound Blade Ultrasound. It will be done at the same visit, right after the SOC ultrasound is complete.
Interventions
Patients who are scheduled for a SOC surveillance Thyroid Nodule Ultrasound after signing consent will undergo a second ultrasound using the Sound Blade Ultrasound. It will be done at the same visit, right after the SOC ultrasound is complete.
Eligibility Criteria
You may qualify if:
- Participants must be ≥ 18 years of age
- Competent to sign informed consent
- Known thyroid nodule demonstrated on a prior thyroid US and is undergoing active surveillance of the nodule with serial USs
You may not qualify if:
- Unable to lay flat for 15 minutes
- Active neck wounds, dressings, or skin conditions that would interfere with neck US (e.g., preclude transducer placement)
- Cervical spine or back disease that would prevent neck extension and would hinder the ability to obtain accurate thyroid US images
- Previous thyroid surgeries, radiation of face and neck
- Known inflammatory thyroid diseases or thyroiditis (e.g., Graves, Hashimoto)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Bayls, MD
Nova Scotia Health Authority
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 27, 2026
First Posted
March 23, 2026
Study Start (Estimated)
May 31, 2026
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
September 1, 2027
Last Updated
March 23, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
This is an internal feasibility study at this point.